Business Context and Reporting Period
This Form 8-K was filed by Seneca Biopharma, Inc. (trading symbol: SNCA) on March 24, 2021. The filing reports on the adjournment of a Special Meeting of Stockholders originally scheduled for that date. Note: The request metadata references "Palisade Bio, Inc.," but the filing text explicitly identifies the registrant as Seneca Biopharma, Inc.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial statement data.
Material Changes
The primary material event reported is the immediate adjournment of the Special Meeting of Stockholders without opening the polls. The meeting was rescheduled to April 9, 2021, at 11:00 a.m. Eastern Time to allow additional time for stockholder votes.
Outlook, Risks, and Unusual Items
- Meeting Format: The reconvened Special Meeting will be held in a virtual-only format via live audio webcast.
- Proxy Voting: Proxies previously submitted will be voted at the adjourned meeting unless properly revoked.
- Exhibits: The filing includes a press release (Exhibit 99.01) and the script read at the Special Meeting (Exhibit 99.02).
Investor Verification Checklist
- Verify the new date and time for the Special Meeting (April 9, 2021, 11:00 a.m. ET).
- Confirm the virtual meeting access details at www.virtualshareholdermeeting.com/SNCA2021SM.
- Review the attached press release (Exhibit 99.01) for specific reasons regarding the vote count or stockholder participation issues.
- Check if any proxies need to be revoked or updated prior to the adjourned meeting.